📣 VC round data is live. Check it out!

Beijing Balance Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Beijing Balance Medical and similar public comparables like Pulse Biosciences, UFP Technologies, MicroPort EP, Heron Neutron Medical and more.

Beijing Balance Medical Overview

About Beijing Balance Medical

Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.


Founded

2005

HQ

China

Employees

N/A

Financials (FY)

Revenue: $92M
EBITDA: $37M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Beijing Balance Medical Financials

Beijing Balance Medical reported last fiscal year revenue of $92M and EBITDA of $37M.

In the same fiscal year, Beijing Balance Medical generated $82M in gross profit, $37M in EBITDA, and $29M in net income.


Beijing Balance Medical P&L

In the most recent fiscal year, Beijing Balance Medical reported revenue of $92M and EBITDA of $37M.

Beijing Balance Medical is profitable as of last fiscal year, with gross margin of 89%, EBITDA margin of 40%, and net margin of 31%.

See analyst estimates for Beijing Balance Medical
Last FY202320242025202620272028
Revenue$92M$55M$74M$92M
Gross Profit$82M$49M$66M$82M
Gross Margin89%90%88%89%
EBITDA$37M$20M$26M$37M
EBITDA Margin40%36%35%40%
EBIT Margin33%28%28%33%
Net Profit$29M$17M$22M$29M
Net Margin31%31%29%31%
Net Debt$5M---

Financial data powered by Morningstar, Inc.

Beijing Balance Medical Stock Performance

Beijing Balance Medical has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Beijing Balance Medical's stock price is $12.29.

Beijing Balance Medical share price increased by 0.9% in the last 30 days, and decreased by 17.6% in the last year.

Beijing Balance Medical has an EPS (earnings per share) of $0.21.

See more trading valuation data for Beijing Balance Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B-1.5%0.9%-15.7%-17.6%$0.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Beijing Balance Medical Valuation Multiples

Beijing Balance Medical trades at 18.2x EV/Revenue multiple, and 45.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Beijing Balance Medical

Beijing Balance Medical Financial Valuation Multiples

As of June 3, 2026, Beijing Balance Medical has market cap of $2B and EV of $2B.

Beijing Balance Medical has a P/E ratio of 59.2x.

Last FY202320242025202620272028
EV/Revenue18.2x30.4x22.4x18.2x
EV/EBITDA45.1x84.0x64.6x45.1x
EV/EBIT54.7x108.0x81.6x54.7x
EV/Gross Profit20.4x33.8x25.4x20.4x
P/E59.2x99.4x78.3x59.2x
EV/FCF182.9xn/mn/m182.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Beijing Balance Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Beijing Balance Medical Margins & Growth Rates

In the most recent fiscal year, Beijing Balance Medical reported gross margin of 89%, EBITDA margin of 40%, and net margin of 31%.

See estimated margins and future growth rates for Beijing Balance Medical

Beijing Balance Medical Margins

Last FY20242025202720282029
Gross Margin89%88%89%
EBITDA Margin40%35%40%
EBIT Margin33%28%33%
Net Margin31%29%31%
FCF Margin10%(5%)10%

Beijing Balance Medical Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth35%24%
Gross Profit Growth33%25%
EBITDA Growth30%43%
EBIT Growth32%49%
Net Profit Growth27%32%
FCF Growth(316%)(328%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Beijing Balance Medical Operational KPIs

Access forward-looking KPIs for Beijing Balance Medical
Last FY202320242025202620272028
S&M Expenses to Revenue14%17%15%14%
G&A Expenses to Revenue2%3%2%2%
R&D Expenses to Revenue25%27%30%25%
Opex to Revenue56%62%61%56%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Beijing Balance Medical Competitors

Beijing Balance Medical competitors include Pulse Biosciences, UFP Technologies, MicroPort EP, Heron Neutron Medical, 4DMedical, Qingdao Baheal Medical, Draegerwerk, Oxford Nanopore Technologies, Embla Medical and BoneSupport.

Most Beijing Balance Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Pulse Biosciences4622.5x1056.5x(32.1x)(28.6x)
UFP Technologies3.0x2.9x15.0x14.4x
MicroPort EP22.3x21.1x117.5x110.9x
Heron Neutron Medical4005.2x-(93.6x)-
4DMedical388.4x325.4x(90.4x)(13.6x)
Qingdao Baheal Medical1.6x1.6x12.8x12.8x
Draegerwerk0.4x0.4x3.9x3.8x
Oxford Nanopore Technologies5.0x4.5x(12.9x)(15.0x)

This data is available for Pro users. Sign up to see all Beijing Balance Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Beijing Balance Medical

When was Beijing Balance Medical founded?Beijing Balance Medical was founded in 2005.
Where is Beijing Balance Medical headquartered?Beijing Balance Medical is headquartered in China.
Is Beijing Balance Medical publicly listed?Yes, Beijing Balance Medical is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Beijing Balance Medical?Beijing Balance Medical trades under 688198 ticker.
When did Beijing Balance Medical go public?Beijing Balance Medical went public in 2019.
Who are competitors of Beijing Balance Medical?Beijing Balance Medical main competitors include Pulse Biosciences, UFP Technologies, MicroPort EP, Heron Neutron Medical, 4DMedical, Qingdao Baheal Medical, Draegerwerk, Oxford Nanopore Technologies, Embla Medical, BoneSupport.
What is the current market cap of Beijing Balance Medical?Beijing Balance Medical's current market cap is $2B.
What is the current revenue of Beijing Balance Medical?Beijing Balance Medical's last fiscal year revenue is $92M.
What is the current EV/Revenue multiple of Beijing Balance Medical?Current revenue multiple of Beijing Balance Medical is 18.2x.
Is Beijing Balance Medical profitable?No, Beijing Balance Medical is not profitable.
How many companies Beijing Balance Medical has acquired to date?Beijing Balance Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Beijing Balance Medical has invested to date?Beijing Balance Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Beijing Balance Medical

Lists including Beijing Balance Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial